Laboratory of Protein Dynamics and Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, United States.
FEBS Lett. 2011 Oct 20;585(20):3166-73. doi: 10.1016/j.febslet.2011.08.031. Epub 2011 Aug 27.
The recent identification of metastasis suppressor genes, the products of which inhibit metastasis but not primary tumor growth, distinguishes oncogenic transformation and tumor suppression from a hallmark of malignancy, the ability of cancer cells to invade sites distant from the primary tumor. The metastasis suppressor CD82/KAI1 is a member of the tetraspanin superfamily of glycoproteins. CD82 suppresses metastasis by multiple mechanisms including inhibition of cell motility and invasion, promotion of cell polarity as well as induction of senescence and apoptosis in response to extracellular stimuli. A common feature of these diverse effects is CD82 regulation of membrane organization as well as protein trafficking and interactions, which affects cellular signaling and intercellular communication.
最近发现的转移抑制基因的产物可以抑制转移但不抑制原发肿瘤的生长,这将致癌转化和肿瘤抑制与癌症的一个重要特征区分开来,即癌细胞能够侵袭远离原发肿瘤的部位。转移抑制因子 CD82/KAI1 是糖蛋白四旋蛋白超家族的成员。CD82 通过多种机制抑制转移,包括抑制细胞迁移和侵袭、促进细胞极性以及对细胞外刺激的衰老和凋亡的诱导。这些不同作用的一个共同特征是 CD82 调节膜组织以及蛋白质运输和相互作用,这影响细胞信号转导和细胞间通讯。